April 4, 2023 11:11 AM EDT
Deals

Gink­go sells Zymer­gen lab to chem­i­cal and ma­te­r­i­al man­u­fac­tur­er Solvay

Paul Schloesser

Associate Editor

Gink­go Bioworks is sell­ing a lab ac­quired through last year’s $300 mil­lion ac­qui­si­tion of Zymer­gen to the multi­na­tion­al chem­i­cal and ma­te­ri­als com­pa­ny Solvay, part …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump picks vac­cine skep­tic Kennedy to lead HHS, in what would be an up­heaval of US health pol­i­cy

Eu­ro­pean drug reg­u­la­tor re­vers­es opin­ion on Ei­sai and Bio­gen's Alzheimer's drug

Gilead will close Philadel­phia, Seat­tle of­fices as part of job re­duc­tions

BeiGene will re­brand to BeOne Med­i­cines, drop­ping name's link to Chi­na roots

Mer­ck buys in­to PD-1/VEGF space as Sum­mit comes for Keytru­da

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times